These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8389563)

  • 1. Comparative renal hemodynamic effects of lisinopril, verapamil, and amlodipine in patients with chronic renal failure.
    August P; Lenz T; Laragh JH
    Am J Hypertens; 1993 Apr; 6(4):148S-154S. PubMed ID: 8389563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
    Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Add-on angiotensin receptor blockade with maximized ACE inhibition.
    Agarwal R
    Kidney Int; 2001 Jun; 59(6):2282-9. PubMed ID: 11380832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic responses to converting enzyme inhibition in patients with renal disease.
    August P; Cody RJ; Sealey JE; Laragh JH
    Am J Hypertens; 1989 Aug; 2(8):599-603. PubMed ID: 2550029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and chronic effects of lisinopril on renal and systemic hemodynamics in hypertension.
    Degaute JP; Leeman M; Reuse C; Carlier E; Schoutens A; Vandepapeliere P
    Cardiovasc Drugs Ther; 1992 Oct; 6(5):489-94. PubMed ID: 1333275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long term effects of sustained release verapamil on the renal and systemic haemodynamic parameters in hypertensive patients with mild to severe chronic renal failure.
    Schohn DC; Jahn HA; Maareck M
    Drugs; 1993; 46 Suppl 2():113-9; discussion 119-20. PubMed ID: 7512464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects of antihypertensive regimens on renal hemodynamics and proteinuria.
    Brown SA; Walton CL; Crawford P; Bakris GL
    Kidney Int; 1993 Jun; 43(6):1210-8. PubMed ID: 8391095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term hemodynamic effects at rest and during exercise of newer antihypertensive agents and salt restriction in essential hypertension: review of epanolol, doxazosin, amlodipine, felodipine, diltiazem, lisinopril, dilevalol, carvedilol, and ketanserin.
    Omvik P; Lund-Johansen P
    Cardiovasc Drugs Ther; 1993 Apr; 7(2):193-206. PubMed ID: 8395198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of light exercise on renal hemodynamics in patients with hypertension and chronic renal disease.
    Svarstad E; Myking O; Ofstad J; Iversen BM
    Scand J Urol Nephrol; 2002; 36(6):464-72. PubMed ID: 12623513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of lisinopril on renal function in proteinuric renal transplant recipients.
    Traindl O; Falger S; Reading S; Banyai M; Liebisch B; Gisinger J; Templ E; Mayer G; Kovarik J
    Transplantation; 1993 Jun; 55(6):1309-13. PubMed ID: 8390733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between the effects of amlodipine and lisinopril on proteinuria in nondiabetic renal failure: a double-blind, randomized prospective study.
    Janssen JJ; Gans RO; van der Meulen J; Pijpers R; ter Wee PM
    Am J Hypertens; 1998 Sep; 11(9):1074-9. PubMed ID: 9752892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitrendipine and amlodipine mimic the acute effects of enalapril on renal haemodynamics and reduce glomerular hyperfiltration in patients with chronic kidney disease.
    Morrone LF; Ramunni A; Fassianos E; Saracino A; Coratelli P; Passavanti G
    J Hum Hypertens; 2003 Jul; 17(7):487-93. PubMed ID: 12821956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension after renal transplantation. Calcium channel or converting enzyme blockade?
    van der Schaaf MR; Hené RJ; Floor M; Blankestijn PJ; Koomans HA
    Hypertension; 1995 Jan; 25(1):77-81. PubMed ID: 7843758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of arterial hypertension in diabetic humans: importance of therapeutic selection.
    Bakris GL; Barnhill BW; Sadler R
    Kidney Int; 1992 Apr; 41(4):912-9. PubMed ID: 1325010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study.
    Iino Y; Hayashi M; Kawamura T; Shiigai T; Tomino Y; Yamada K; Kitajima T; Ideura T; Koyama A; Sugisaki T; Suzuki H; Umemura S; Kawaguchi Y; Uchida S; Kuwahara M; Yamazaki T;
    Clin Exp Nephrol; 2003 Sep; 7(3):221-30. PubMed ID: 14586719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin-A receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure: a comparison of selective and combined endothelin receptor blockade.
    Goddard J; Johnston NR; Hand MF; Cumming AD; Rabelink TJ; Rankin AJ; Webb DJ
    Circulation; 2004 Mar; 109(9):1186-93. PubMed ID: 14981006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic responses to verapamil monotherapy in patients with renal disease.
    Lenz T; Müller FB; Sotelo JE; Laragh JH; August P
    Am J Hypertens; 1991 Dec; 4(12 Pt 1):939-43. PubMed ID: 1815650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Verapamil alters the relationship between renal perfusion pressure and glomerular filtration rate and renin release: the mechanism of the antihypertensive effect.
    Lin HB; Young DB
    J Cardiovasc Pharmacol; 1988; 12 Suppl 6():S57-9. PubMed ID: 2468908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of sustained-release verapamil on hemodynamics and renal function of patients with moderate to severe chronic renal failure].
    Schohn D; Maarek M; Jahn H
    Presse Med; 1993 Nov; 22(37):1856-60. PubMed ID: 8115329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.